Does continuous positive airway pressure reduce aldosterone levels in patients with obstructive sleep apnea? (Q35896763)

11 August 2017

0 references

Does continuous positive airway pressure reduce aldosterone levels in patients with obstructive sleep apnea? (English)

1 reference

11 August 2017

Si-Jiu Yang

1

1 reference

11 August 2017

Xing-Tang Jiang

2

1 reference

11 August 2017

Xiao-Bin Zhang

3

1 reference

11 August 2017

Xiao-Wen Yin

4

1 reference

11 August 2017

Wei-Xian Deng

5

1 reference

11 August 2017

publication date

15 January 2016

1 reference

11 August 2017

1 reference

11 August 2017

volume

20

1 reference

11 August 2017

issue

3

1 reference

11 August 2017

page(s)

921-928

1 reference

Obstructive sleep apnoea syndrome as a risk factor for hypertension: population study

11 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11325-015-1311-Y

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11325-015-1311-Y

Sympathetic neural mechanisms in obstructive sleep apnea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11325-015-1311-Y

Inflammation, oxidative stress, and repair capacity of the vascular endothelium in obstructive sleep apnea

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11325-015-1311-Y

Resistant hypertension, obstructive sleep apnoea and aldosterone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11325-015-1311-Y

Plasma aldosterone is related to severity of obstructive sleep apnea in subjects with resistant hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11325-015-1311-Y

Serum aldosterone and the incidence of hypertension in nonhypertensive persons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11325-015-1311-Y

Continuous positive airway pressure treatment in sleep apnea patients with resistant hypertension: a randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11325-015-1311-Y

Effect of CPAP on blood pressure in patients with obstructive sleep apnea and resistant hypertension: the HIPARCO randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11325-015-1311-Y

Effects of OSA treatment on BP in patients with resistant hypertension: a randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11325-015-1311-Y

Ambulatory blood pressure after therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomised parallel trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11325-015-1311-Y

Estimating the mean and variance from the median, range, and the size of a sample

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11325-015-1311-Y

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11325-015-1311-Y

Endocrine effects of nasal continuous positive airway pressure in male patients with obstructive sleep apnoea

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11325-015-1311-Y

Abnormal vasoactive hormones and 24-hour blood pressure in obstructive sleep apnea

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11325-015-1311-Y

Relationship between aldosterone and the metabolic syndrome in patients with obstructive sleep apnea hypopnea syndrome: effect of continuous positive airway pressure treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11325-015-1311-Y

A randomized controlled study of CPAP effect on plasma aldosterone concentration in patients with resistant hypertension and obstructive sleep apnea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11325-015-1311-Y

The new biology of aldosterone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11325-015-1311-Y

50th anniversary of aldosterone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11325-015-1311-Y

Sleep apnea, aldosterone, and resistant hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11325-015-1311-Y

Obesity, sleep apnea, aldosterone, and hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11325-015-1311-Y

Continuous positive airway pressure therapy for treating sleepiness in a diverse population with obstructive sleep apnea: results of a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11325-015-1311-Y

Sympathetic over activity in the etiology of hypertension of obstructive sleep apnea.

21 January 2018

1 reference

12 December 2020

[Significance of the changes of urinary uric acid, ANP, renin and aldosterone in sleep apnea syndrome patients]

1 reference

12 December 2020

Obstructive sleep apnea and cardiovascular disease

1 reference

12 December 2020

Effects of nasal continuous positive airway pressure (NCPAP) on nocturnal renal function in obstructive sleep apnea syndrome (OSAS)

1 reference

12 December 2020

Effect of nasal CPAP treatment on plasma volume, aldosterone and 24-h blood pressure in obstructive sleep apnoea

1 reference

12 December 2020

Obstructive sleep apnea treatment: peripheral and central effects on plasma renin activity and aldosterone

1 reference

12 December 2020

Obstructive sleep apnea and aldosterone.

1 reference

12 December 2020

Efficacy of continuous positive airway pressure therapy upon resistant hypertension in patients with obstructive sleep apnea hypopnea syndrome

1 reference

12 December 2020

10.1007/S11325-015-1311-Y

Identifiers

DOI

1 reference

11 August 2017

1 reference